ATARA BIOTHERAPEUTICS, INC. Capital Expenditures Incurred but Not yet Paid
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Capital Expenditures Incurred but Not yet Paid of $0 for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:CapitalExpendituresIncurredButNotYetPaid · last filed 2025-05-15
- ATARA BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2025-03-31 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-09-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for the quarter ending 2024-06-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- ATARA BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2023 was $132.00K, a 116.39% increase from fiscal 2022.
- ATARA BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2022 was $61.00K, a 97.15% decline from fiscal 2021.
- ATARA BIOTHERAPEUTICS, INC. capital expenditures incurred but not yet paid for fiscal 2021 was $2.14M, a 556.13% increase from fiscal 2020.
| Period end | Capital Expenditures Incurred but Not yet Paid 3 month | Capital Expenditures Incurred but Not yet Paid 6 month | Capital Expenditures Incurred but Not yet Paid 9 month | Capital Expenditures Incurred but Not yet Paid 12 month |
|---|---|---|---|---|
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-05-15 | $0.00 derived: sum of 3 quarters · filed 2025-05-15 | $0.00 derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $0.00 derived: sum of 2 quarters · filed 2025-03-07 | $0.00 derived: sum of 3 quarters · filed 2025-03-07 | $0.00 10-K · filed 2025-03-07 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $0.00 10-Q · filed 2024-11-12 | $112.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $0.00 10-Q · filed 2024-08-12 | $112.00K derived: sum of 3 quarters · filed 2025-05-15 | $24.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-15 | $112.00K derived: sum of 2 quarters · filed 2025-05-15 | $24.00K derived: sum of 3 quarters · filed 2025-05-15 | -$62.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $112.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $24.00K derived: sum of 2 quarters · filed 2025-03-07 | -$62.00K derived: sum of 3 quarters · filed 2025-03-07 | $132.00K 10-K · filed 2025-03-07 |
| 2023-09-30 | -$88.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$174.00K derived: sum of 2 quarters · filed 2024-11-12 | $20.00K 10-Q · filed 2024-11-12 | $46.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$86.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $108.00K 10-Q · filed 2024-08-12 | $134.00K derived: sum of 3 quarters · filed 2024-08-12 | $37.00K derived: sum of 4 quarters · filed 2024-08-12 |
| 2023-03-31 | $194.00K 10-Q · filed 2024-05-09 | $220.00K derived: sum of 2 quarters · filed 2024-05-09 | $123.00K derived: sum of 3 quarters · filed 2024-05-09 | -$933.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | -$71.00K derived: sum of 2 quarters · filed 2024-03-28 | -$1.13M derived: sum of 3 quarters · filed 2024-03-28 | $61.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | -$97.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$1.15M derived: sum of 2 quarters · filed 2023-11-01 | $35.00K 10-Q · filed 2023-11-01 | $316.00K derived: sum of 4 quarters · filed 2023-11-01 |
| 2022-06-30 | -$1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $132.00K 10-Q · filed 2023-08-08 | $413.00K derived: sum of 3 quarters · filed 2023-08-08 | $1.27M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.19M 10-Q · filed 2023-05-08 | $1.47M derived: sum of 2 quarters · filed 2023-05-08 | $2.33M derived: sum of 3 quarters · filed 2023-05-08 | $2.08M derived: sum of 4 quarters · filed 2023-05-08 |
| 2021-12-31 | $281.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $1.14M derived: sum of 2 quarters · filed 2023-02-08 | $894.00K derived: sum of 3 quarters · filed 2023-02-08 | $2.14M 10-K · filed 2023-02-08 |
| 2021-09-30 | $858.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $613.00K derived: sum of 2 quarters · filed 2022-11-08 | $1.86M 10-Q · filed 2022-11-08 | $1.95M derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-06-30 | -$245.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.00M 10-Q · filed 2022-08-08 | $1.10M derived: sum of 3 quarters · filed 2023-02-08 | $1.07M derived: sum of 4 quarters · filed 2023-02-08 |
| 2021-03-31 | $1.25M 10-Q · filed 2022-05-05 | $1.34M derived: sum of 2 quarters · filed 2023-02-08 | $1.32M derived: sum of 3 quarters · filed 2023-02-08 | $473.00K derived: sum of 4 quarters · filed 2023-02-08 |
| 2020-12-31 | $96.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-08 | $73.00K derived: sum of 2 quarters · filed 2023-02-08 | -$772.00K derived: sum of 3 quarters · filed 2023-02-08 | $326.00K 10-K · filed 2023-02-08 |
| 2020-09-30 | -$23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$868.00K derived: sum of 2 quarters · filed 2021-11-04 | $230.00K 10-Q · filed 2021-11-04 | -$193.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$845.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $253.00K 10-Q · filed 2021-08-09 | -$170.00K derived: sum of 3 quarters · filed 2022-02-28 | $56.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $1.10M 10-Q · filed 2021-05-04 | $675.00K derived: sum of 2 quarters · filed 2022-02-28 | $901.00K derived: sum of 3 quarters · filed 2022-02-28 | $708.00K derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$423.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$197.00K derived: sum of 2 quarters · filed 2022-02-28 | -$390.00K derived: sum of 3 quarters · filed 2022-02-28 | $276.00K 10-K · filed 2022-02-28 |
| 2019-09-30 | $226.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $33.00K derived: sum of 2 quarters · filed 2020-11-09 | $699.00K 10-Q · filed 2020-11-09 | -$1.70M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $473.00K 10-Q · filed 2020-08-05 | -$1.92M derived: sum of 3 quarters · filed 2021-03-01 | -$3.03M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $666.00K 10-Q · filed 2020-05-06 | -$1.73M derived: sum of 2 quarters · filed 2021-03-01 | -$2.83M derived: sum of 3 quarters · filed 2021-03-01 | -$1.86M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | -$2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$3.50M derived: sum of 2 quarters · filed 2021-03-01 | -$2.53M derived: sum of 3 quarters · filed 2021-03-01 | $1.58M 10-K · filed 2021-03-01 |
| 2018-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$132.00K derived: sum of 2 quarters · filed 2019-11-07 | $3.97M 10-Q · filed 2019-11-07 | $11.03M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $973.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $5.08M 10-Q · filed 2019-08-08 | $12.14M derived: sum of 3 quarters · filed 2020-02-27 | $12.70M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $4.11M 10-Q · filed 2019-05-09 | $11.16M derived: sum of 2 quarters · filed 2020-02-27 | $11.72M derived: sum of 3 quarters · filed 2020-02-27 | $14.02M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $7.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $7.62M derived: sum of 2 quarters · filed 2020-02-27 | $9.91M derived: sum of 3 quarters · filed 2020-02-27 | $10.12M 10-K · filed 2020-02-27 |
| 2017-09-30 | $562.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $2.86M derived: sum of 2 quarters · filed 2018-11-06 | $3.06M 10-Q · filed 2018-11-06 | $3.29M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $2.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $2.50M 10-Q · filed 2018-08-01 | $2.73M derived: sum of 3 quarters · filed 2019-02-26 | $2.35M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $207.00K 10-Q · filed 2018-05-08 | $430.00K derived: sum of 2 quarters · filed 2019-02-26 | $56.00K derived: sum of 3 quarters · filed 2019-02-26 | $559.00K derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $223.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$151.00K derived: sum of 2 quarters · filed 2019-02-26 | $352.00K derived: sum of 3 quarters · filed 2019-02-26 | $352.00K 10-K · filed 2019-02-26 |
| 2016-09-30 | -$374.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $129.00K derived: sum of 2 quarters · filed 2017-11-09 | $129.00K 10-Q · filed 2017-11-09 | $129.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $503.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $503.00K 10-Q · filed 2017-08-07 | $503.00K derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-04 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $0.00 10-Q · filed 2016-11-04 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |